
Class action filed against Capricor Therapeutics over alleged misleading FDA approval info
A class action lawsuit has been filed against Capricor Therapeutics and some of its officers for allegedly making false statements about FDA approval risks related to their drug Deramiocel. The complaint claims Capricor changed its clinical data anal...

